Pharmaron Beijing announces extraordinary general meeting, H share class meeting

• Pharmaron will hold an extraordinary general meeting in Beijing on Sept. 10, 2026.
• Shareholders will vote on adopting a 2026 H Share Award and Trust Scheme covering up to 28,000,000 H shares.
• Decision set on an H-share repurchase mandate, capped at 1.9511% of total shares outstanding, excluding treasury shares.
• Agenda includes authorization to issue offshore debt financing instruments.
• Proposals also cover amendments to the articles of association, general meeting procedures, and the external guarantee management policy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmaron Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12298890), on August 25, 2026, and is solely responsible for the information contained therein.